Keyphrases
Mechanism-based Therapy
100%
Recurrent or Metastatic
100%
Merkel Cell Carcinoma
100%
Metastatic Merkel Cell Carcinoma
100%
Cytotoxic Chemotherapy
33%
Immune Function
16%
High Morbidity
16%
Skin Cancer
16%
Chemotherapy
16%
Treatment Strategy
16%
Clinical Trials
16%
Recurrent Disease
16%
FDA-approved Drugs
16%
Low Toxicity
16%
Metastasis
16%
Immunocompromised Patients
16%
Viral Antigens
16%
Effective Treatment
16%
Immune System
16%
Mechanism-based
16%
Disease Progression
16%
Disease-modifying Therapy
16%
Increased Incidence
16%
Metastatic Disease
16%
Increased Mortality
16%
Median Survival
16%
Immune Suppression
16%
Durable Response
16%
Management Options
16%
Traditional Treatment
16%
Virus-associated Cancer
16%
Polyomavirus
16%
Novel Immunotherapy
16%
Initial Management
16%
Disease-specific Mortality
16%
NCCN Guidelines
16%
Medicine and Dentistry
Merkel Cell Carcinoma
100%
Malignant Neoplasm
57%
Metastatic Carcinoma
28%
Cytotoxic Chemotherapy
28%
Diseases
28%
Clinical Trial
14%
Recurrent Disease
14%
Virus Antigen
14%
Immunotherapy
14%
Immunosuppressive Treatment
14%
Single Drug Dose
14%
Disease Exacerbation
14%
Immunosuppressive Drug
14%
Immune Function
14%
Skin Cancer
14%
Immunocompromised Patient
14%
Polyomavirus
14%
Immune System
14%
Virus
14%